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Abstract
As the number of dental-related randomized clinical trials (RCTs) increases, there is a need for
literature to help investigators inexperienced in conducting RCTs design and implement studies.
This commentary describes four “lessons learned,” or considerations important in the planning and
initial implementation of RCTs in dentistry that to our knowledge have not been discussed in the
general dental literature describing trial techniques. These considerations are 1) preparing or
securing a thorough systematic review, 2) developing a comprehensive set of study documents, 3)
designing and testing multiple recruitment strategies, and 4) employing a run-in period prior to
enrollment. Attention to these considerations in the planning phases of a dental RCT can help
ensure that the trial is clinically relevant while also maximizing the likelihood that its
implementation will be successful.
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The demand for “evidence” continues to escalate as the dental profession increases its
reliance on the precepts of evidence-based dentistry when making both clinical decisions
and policy recommendations.1 This escalation has underscored the relative paucity of well-
conducted randomized clinical trials (RCTs) that test the effectiveness of caries preventive
agents in a variety of populations.2 There are some signs that this need for evidence is being
recognized. The number of RCTs published annually that examine effectiveness of methods
for the prevention and management of dental caries has approximately doubled every five
years since 1993, from 6 in that year, to 11 in 1998, 16 in 2003, and 32 in 2008.
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Additionally, the National Institute of Dental and Craniofacial Research (NIDCR) now
supports Phase I, II, and III clinical trials designed to identify effective preventive,
diagnostic, and treatment approaches for oral and craniofacial diseases and disorders.3
To sustain future growth of RCTs testing caries prevention and treatment methods,
additional investigators who have not had the benefit of previous clinical trial experience
will be needed to plan and conduct the studies. While most clinical dental studies will afford
investigators a variety of opportunities to learn clinical research techniques, some aspects of
the planning and conduct of dental RCTs are unique to the genre,4 and becoming familiar
with them requires either experience with RCTs or directed didactic learning. Reading
reports of clinical trials, becoming familiar with the CONSORT statement,5 and studying
texts are all useful methods of directed learning, but all tend to emphasize statistical and
design issues while offering the reader less in the way of techniques useful in planning and
implementing the trial.
We are not aware of other reports written for dental investigators that discuss such
techniques. Thus, the purpose of this brief commentary is to describe four “lessons learned,”
or techniques that we found to be critically important in planning and conducting a multi-
site RCT that evaluates the effectiveness of a caries preventive agent (the Xylitol for Adult
Caries Trial, or X-ACT). The four techniques are 1) preparing, or securing a thorough
systematic review, 2) developing a comprehensive set of study documents, 3) designing and
testing multiple recruitment strategies, and 4) including a run-in period in the recruitment
phase of the trial.
Thorough Systematic Review
Most trials are preceded by a literature review to justify the study hypothesis, determine
sample size for the proposed trial, and demonstrate the need for the new information to be
generated by the trial. However, all literature reviews are not equal, and will not necessarily
offer the same degree of guidance to the investigators. Performing a systematic review, or
reviewing available pertinent recent systematic reviews prior to preparing a research
proposal, can substantially strengthen that proposal and subsequent clinical trial.
If important studies are missed or disregarded by the reviewer, pertinent information about
the proposed intervention may be missed. As a result, the basis for the trial may be
misstated, or information that would be useful in designing the intervention may be
overlooked. By design, systematic reviews require exhaustive searches of the periodic and
grey literature, with identification of pertinent studies accomplished independently by at
least two investigators.6 Thus it is unlikely that pertinent studies will be missed.
Systematic reviews also require assessments of the quality of the included studies.
Performing these assessments can afford investigators a detailed understanding of the design
features and performance standards considered necessary for high-quality trials. Just as
importantly, systematic reviews are expected to address the strengths and weaknesses of the
available evidence.6 Completing the review provides investigators an opportunity to reflect
on necessary steps to improve on, rather than simply replicate, any existing trials addressing
the research question.
One other feature of systematic reviews useful in planning a clinical trial is the expectation
that a systematic review address one or more focused clinical questions, usually stated in the
“PICO” (Problem, Intervention, Comparison, Outcome) format. Formulating these
questions, which will closely parallel the statement of specific aims of a research proposal,
should help investigators design a trial that provides information that is immediately
applicable to clinical care. The ability to cite a systematic review and summarize its findings
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and research recommendations concisely will also pay dividends under the new NIH brevity
requirements.7
Our clinical trial evaluates the effectiveness of xylitol lozenges in reducing the incidence of
caries in caries-active adults. We benefited both from preparing a systematic review, and
from an existing systematic review. Our interest in evaluating the effectiveness of xylitol in
a high-risk adult population arose from a systematic review8 prepared for the Consensus
Development Conference on the Diagnosis and Management of Dental Caries Throughout
Life,2 which later appeared in the periodic scientific literature.9 Preparing this review alerted
us both to the potential of xylitol for caries prevention and to the dearth of studies examining
caries prevention in high-caries-risk adults. The existing systematic review of xylitol’s
effectiveness10 clearly identified crucial design weaknesses of existing trials that we were
able to address in our design.
Comprehensive Set of Study Documents
A successful clinical trial requires a lengthy planning period before it is launched, and that
planning will be embodied in several study documents, including a study protocol, a manual
of procedures (MOP) or manual of operations (MOO), and possibly documents for Food and
Drug Administration (FDA) and Office of Human Research Protections (OHRP)
requirements. The process of preparing study documents for a clinical trial provides
investigators an opportunity for thorough and unhurried deliberation to design and test
details of various trial elements. In contrast to an observational study, clinical trial
investigators make an educated assumption about the possible effects of an intervention,
agree to a design before study launch and test the approved design in a rigorous manner for
the entire study period (typically two to four years) with very little modification. Therefore,
careful planning is needed before the study is launched.
While many clinical trial elements, such as data management, training and monitoring
procedures may be relatively simple applications of existing “off the shelf” systems used by
data coordinating centers, other elements may demand more complex adaptation, if not de
novo development. Such development could seriously delay initiation of the trial, or if
rushed, compromise its internal validity. As an example, in the X-ACT trial, an adaptation
of the International Caries Detection and Assessment System (ICDAS) caries recording
method11 was to be used. This required the design of an examiner and recorder training
curriculum, development of recording forms, and specification of weights for all possible
transitions in the transition matrix. The development of these items required an unexpectedly
long time, and could have delayed the start of enrollment and baseline examinations had
they not been developed prior to funding of the final clinical trial.
The study protocol is the final design document wherein the final primary outcome measure
must be articulated together with secondary measures and the statistical plan and sample size
justification.12 All procedures and materials related to human subjects, such as advertising
materials, recruitment procedures, and consent are included and submitted to an Institutional
Review Board (IRB) for approval. If the investigators have taken advantage of pre-review
advice offered by some IRBs during protocol development, prompt approval is made more
likely. Details that may change throughout the trial that do not impact study design or
human subjects concerns (such as location of screening visit or dates for lozenge resupply)
should not be included in the protocol, as any changes must be approved by the IRB. These
are typically included in the Manual of Procedures (MOP) or Manual of Operations (MOO)
The MOP contains complete descriptions of all roles and responsibilities, which facilitates
recruitment and training of trial personnel once trial funding has been obtained. In addition,
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because clinical trials typically run several years, staff turnover is a reality. With a detailed,
site-specific MOP, the learning curve for new personnel is reduced. Other advantages of a
pretrial MOP are related to the establishment of clear policies and procedures for a variety of
potentially divisive decisions to be taken later in the operation of the trial. For example, a
MOP may contain policies on publication, including authorship, or it may identify a
publication committee charged with developing those policies. Because sites may have
different operating policies, development of the MOP should involve members of the
investigative team from all participating sites. Procedures and forms developed by a smaller
subset of investigators may not be transferable to other participating organizations. Also,
developing the MOP offers the opportunity to form working relationships necessary for
successful collaboration at an early stage in the trial. The MOP is a dynamic document that
changes as needed to refine procedures. Any changes to the MOP or to the study protocol
must be tracked, so the MOP format should be one that allows easy updating and tracking.
Multiple Recruitment Strategies
Recruitment is a basic component of trial planning, but the extent to which recruitment
strategies need to be developed and refined prior to the initiation of the trial can easily be
underestimated. Sources of potentially eligible participants should be identified, and for each
source, methods to approach potential participants should be fully developed and, ideally,
should be tested prior to initiation of the trial. The recruitment strategy designated as
primary, that is the strategy that will be employed first in the recruitment phase of the trial,
will usually represent the most cost-effective means of offering opportunities for
participation. This designation will be based on assumptions about the rate of availability of
potential participants and the likelihood of both their interest and eligibility for enrollment.
It is critical that these assumptions be tested during the planning phase of the trial. It is
equally important to have multiple secondary, or “back-up” recruitment strategies developed
to the point of implementation, in the event that the primary strategy fails to perform as well
as expected. While increasing the compensation for participation may be one of the back-up
strategy, caution should be exercised with this approach. The line between compensation
and coercion is not easy to identify, and paying more may be frowned upon by both the IRB
and other investigators who find the expectations of potential participants raised.
In the X-ACT study, the methods actually used for recruiting participants varied greatly
across the three clinical sites, despite a uniform planned primary strategy involving
recruitment from dental school clinics. Pre-testing at one site indicated that this strategy
would be efficient and effective. However, once recruitment began, another site found that
the flow of patients through the clinic was inadequate. A back-up strategy was successfully
initiated that involved recruiting from community dental clinics using posters and flyers
distributed with the help of clinic staff. A third site found that when the school clinic yield
was less than expected, it had to employ mass media advertisement to the local population at
large through newspaper and radio ads. This unplanned change in strategy caused IRB
delays, increased the budget, and required more staff time to handle inquiries and
screenings. The site where the original strategy was tested found the patient flow from the
dental school clinic adequate, but that a “prescreening approach” to target recruitment
efforts was necessary for greater efficiency, as staff time required was greater than
anticipated. Thus, despite a reasonably well-planned and tested primary recruitment strategy,
two of three sites needed to employ secondary strategies, and the third site had to modify the
strategy to operate within available staff time. More complete pilot-testing of the strategy in
all three sites may have provided more accurate estimates of potential participant interest
and flow per week, yielding more realistic staffing, facility and budgeting projections.
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A design feature that is seldom used in dental trials is the “run-in” period.13 The run-in
permits potential participants to experience the actual trial procedures prior to entering the
trial and being randomized to a treatment arm. Run-in periods are of value in identifying
ineligible participants and in establishing that participants are capable of accomplishing trial
procedures. If participants’ current treatments are discontinued, the feature is sometimes
termed a washout period. Perhaps the greatest benefit of a run-in period is the opportunity it
affords potential participants to decide if they can adhere to the trial regimen for the
projected duration of the trial. Allowing participants to make this decision after experiencing
the regimen should reduce subsequent dropout, but at the potential cost of weakening
generalizability.14
Run-in periods can offer a means of reducing dropouts and poor adherence particularly for
dental trials where participant adherence involves oral care routines. Certainly, in the X-
ACT trial wherein participants were expected to let a lozenge dissolve in their mouths five
times a day for three years, adherence to the study regimen was an important consideration.
We asked potential participants to begin the trial with a four-week run-in period during
which they would consume placebo lozenges according to the study regimen. We stressed
that either they or the study coordinator could decide to discontinue further participation
based on this experience. We found that the run-in period was effective in making potential
participants aware of their long-term adherence responsibilities, with the result that of 945
individuals initially admitted into the trial’s four-week run-in period, 81 (8.6%) terminated
prior to the end of the run-in period. Of the 864 individuals completing the run-in, 173
(20.0%) were not randomized and therefore did not formally enter the trial. Overall, 26.8%
of potential participants did not enter the trial after experiencing the regimen during the run-
in period. The majority of this group decided not to enroll because of the burden that long-
term adherence represented.
These then are four important “lessons learned” from the X-ACT trial that we believe may
prove useful to other investigators. Design the study based on learnings from a systematic
review, develop a protocol and comprehensive MOP in advance of the grant application that
would fund the full trial, plan and test multiple recruitment strategies before recruitment
begins, and when indicated, use a run-in period to help minimize dropouts and poor
adherence during the trial. Of course, attention to these four lessons alone will not ensure
success. Problems can arise with virtually any aspect of a trial. Thus, seeking the advice of
persons experienced in trial design and management will always be a method to benefit from
others’ lessons learned.
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